Inhibition of DYRK1A Stimulates Human β-Cell Proliferation

Abstract excerpt

Restoring functional β-cell mass is an important therapeutic goal for both type 1 and type 2 diabetes (1). While proliferation of existing β-cells is the primary means of β-cell replacement in rodents (2), it is unclear whether a similar principle applies to humans, as human β-cells are remarkably resistant to stimulation of division (3,4). Here, we show that 5-iodotubercidin (5-IT), an annotated adenosine kinase...

Topics

Join the communities discussing this publication.

• Diabetes Management and Research
• Genetics and Neurodevelopmental Disorders
• Pancreatic function and diabetes